Synonym
150085-21-5; S1R agonist; S1R agonist-2; S1R-agonist-2; Compound 8b
IUPAC/Chemical Name
4-benzyl-1-(3-phenoxypropyl)piperidine
InChi Key
KOYQYIAABUPJFF-UHFFFAOYSA-N
InChi Code
InChI=1S/C21H27NO/c1-3-8-19(9-4-1)18-20-12-15-22(16-13-20)14-7-17-23-21-10-5-2-6-11-21/h1-6,8-11,20H,7,12-18H2
SMILES Code
C1(OCCCN2CCC(CC2)CC3=CC=CC=C3)=CC=CC=C1
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
309.45
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Váczi S, Barna L, Harazin A, Mészáros M, Porkoláb G, Zvara Á, Ónody R,
Földesi I, Veszelka S, Penke B, Fülöp L, Deli MA, Mezei Z. S1R agonist modulates
rat platelet eicosanoid synthesis and aggregation. Platelets. 2022 Jul
4;33(5):709-718. doi: 10.1080/09537104.2021.1981843. Epub 2021 Oct 26. PMID:
34697991.
2: Dalwadi DA, Kim S, Schetz J, Schreihofer DA, Kim S. Brain-derived
neurotrophic factor for high-throughput evaluation of selective Sigma-1 receptor
ligands. J Pharmacol Toxicol Methods. 2022 Jan-Feb;113:107129. doi:
10.1016/j.vascn.2021.107129. Epub 2021 Oct 20. PMID: 34678430; PMCID:
PMC9358981.
3: Mavlyutov TA, Baker EM, Losenegger TM, Kim JR, Torres B, Epstein ML, Ruoho
AE. The Sigma-1 Receptor-A Therapeutic Target for the Treatment of ALS? Adv Exp
Med Biol. 2017;964:255-265. doi: 10.1007/978-3-319-50174-1_17. PMID: 28315276.
4: Zhemkov V, Geva M, Hayden MR, Bezprozvanny I. Sigma-1 Receptor (S1R)
Interaction with Cholesterol: Mechanisms of S1R Activation and Its Role in
Neurodegenerative Diseases. Int J Mol Sci. 2021 Apr 15;22(8):4082. doi:
10.3390/ijms22084082. PMID: 33920913; PMCID: PMC8071319.
5: Dichiara M, Ambrosio FA, Barbaraci C, González-Cano R, Costa G, Parenti C,
Marrazzo A, Pasquinucci L, Cobos EJ, Alcaro S, Amata E. Synthesis, Computational
Insights, and Evaluation of Novel Sigma Receptors Ligands. ACS Chem Neurosci.
2023 May 17;14(10):1845-1858. doi: 10.1021/acschemneuro.3c00074. Epub 2023 May
8. PMID: 37155827; PMCID: PMC10197133.
